Related Experiment Video
Updated: Feb 15, 2026

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
Role and regulation of Yap in KrasG12D-induced lung cancer
Yaopan Mao1, Shuguo Sun1,1, Kenneth D Irvine1
1Waksman Institute, Cancer Institute of New Jersey, Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08854, USA.
Abstract:
The Hippo pathway and its downstream transcriptional co-activator Yap influence lung cancer, but the nature of the Yap contribution has been unclear. Using a genetically engineered mouse lung cancer model, we show that Yap deletion completely blocks KrasG12D and p53 loss-driven adenocarcinoma initiation and progression, whereas heterozygosity for Yap partially suppresses lung cancer growth and progression. We also characterize Yap expression during tumor progression and find that nuclear Yap can be detected from the earliest stages of lung carcinogenesis, but at levels comparable to that in aveolar type II cells, which are a cell of origin for lung adenocarcinoma. At later stages of tumorigenesis, variations in Yap levels are detected, which correlate with differences in cell proliferation within tumors. Our observations imply that Yap is not directly activated by oncogenic Kras during lung tumorigenesis, but is nonetheless absolutely required for this tumorigenesis, and support Yap as a therapeutic target in lung adenocarcinoma.
Insights
The Hippo pathway
Area of Science:
- Oncology
- Molecular Biology
Background:
- The Hippo pathway and its downstream transcriptional co-activator Yap are implicated in lung cancer.
- The precise role of Yap in lung tumorigenesis remains incompletely understood.
Purpose of the Study:
- To elucidate the role of Yap in KrasG12D and p53 loss-driven lung adenocarcinoma initiation and progression.
- To characterize Yap expression patterns during lung tumor development.
Main Methods:
- Utilized a genetically engineered mouse model of lung cancer.
- Investigated the effects of Yap deletion and heterozygosity on tumor initiation and progression.
- Analyzed Yap expression levels at various stages of tumorigenesis.
Main Results:
- Complete Yap deletion abolished KrasG12D and p53 loss-driven lung adenocarcinoma initiation and progression.
- Partial Yap suppression (heterozygosity) partially inhibited lung cancer growth.
- Nuclear Yap was detected early in lung carcinogenesis, with levels correlating with proliferation in later stages.
Conclusions:
- Yap is essential for KrasG12D and p53 loss-driven lung tumorigenesis, despite not being directly activated by oncogenic Kras.
- Yap represents a potential therapeutic target for lung adenocarcinoma.
Related Concept Videos
Hormonal Regulation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GTPases and their Regulation
Large G-proteins,...
Mechanisms of Retrovirus-induced Cancers
Lung Capacity
Master Transcription Regulators

